12:00 AM
 | 
Nov 02, 2015
 |  BC Week In Review  |  Clinical News  |  Clinical Results

RosettaGX Reveal: Clinical trial data

Data from 192 fine needle aspiration (FNA) smears in a blinded, international validation study showed that when the final diagnosis was unanimously confirmed by 3 pathologists, Rosetta’s RosettaGX Reveal assay had...

Read the full 135 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >